Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Comparative risk factors among pancreatic adenocarcinoma patients vs. neuroendocrine and other pancreatic cancer patients.
Journal: Cancer causes & control : CCC
Published: March 17, 2026
Racial and ethnic disparities in prior authorizations for patients with cancer.
Journal: The American journal of managed care
Published: October 28, 2024
Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 02, 2024
Cancer Treatment Before and After Physician-Pharmacy Integration.
Journal: JAMA network open
Published: May 23, 2024
Trends in low-value cancer care during the COVID-19 pandemic.
Journal: The American journal of managed care
Published: April 11, 2024
Immunotherapy in combination with chemotherapy vs. immunotherapy alone for advanced non-small cell lung cancer and programmed death ligand 1 score <50.
Journal: Cancer treatment and research communications
Published: July 27, 2023
Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
Journal: JCO oncology practice
Published: June 29, 2023
Trends in Medically Integrated Dispensing Among Oncology Practices.
Journal: JCO oncology practice
Published: July 13, 2022
Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 14, 2021
Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study.
Journal: Patient preference and adherence
Published: May 11, 2021
Association Between a National Insurer's Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 06, 2020
Last Updated: 09/26/2026